[Cimetidine and ranitidine in the treatment of reflux esophagitis].
Kimmig Jm
Abstract
Kimmig Jm
Abstract
The efficacy of the two H2-receptor-antagonists cimetidine (2 X 400 mg/die) and ranitidine (2 X 150 mg/die) for reflux oesophagitis was compared. 128 patients with endoscopically proven reflux oesophagitis in stages I and II based on the criteria of Savary and Miller took part in the trial on an out patients basis. Both drugs healed the oesophagus lesions in 70% of the patients after 6 weeks treatment. After 12 weeks, 90% of stage I patients and 80-85% of stage II patients were completely healed with both H2-antagonists. No significant difference was seen between the two drugs either with respect to the healing of the lesions or to the symptomatic improvement.
OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The efficacy of the two H2-receptor-antagonists cimetidine (2 X 400 mg/die) and ranitidine (2 X 150 mg/die) for reflux oesophagitis was compared. 128 patients with endoscopically proven reflux oesophagitis in stages I and II based on the criteria of Savary and Miller took part in the trial on an out patients basis. Both drugs healed the oesophagus lesions in 70% of the patients after 6 weeks treatment. After 12 weeks, 90% of stage I patients and 80-85% of stage II patients were completely healed with both H2-antagonists. No significant difference was seen between the two drugs either with respect to the healing of the lesions or to the symptomatic improvement.
Key concepts: Cimetidine, Ranitidine, Medicine, Reflux, Gastroenterology, Reflux esophagitis, Esophagitis, Internal medicine